相关实验视频
Updated: May 22, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
对于Mdm4抑制p53活动的Mdm2的依赖性
Shunbin Xiong1, Yun Zhang2, Xin Zhou3
1Department of Genetics, UT M.D. Anderson Cancer Center, Houston, TX, USA.
Cancer letters
|March 13, 2025
概括
Mdm4通过与Mdm2.2相互作用来抑制瘤抑制剂p53. 鼠标模型显示Mdm4
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- Mdm2和Mdm4是瘤抑制剂p53.4的关键负调节剂.
- Mdm2在p53中无处不在,使其成为降解的目标.
- Mdm4 抑制了 p53 的转录活性,并与 Mdm2.2 进行异构.
研究的目的:
- 阐明Mdm4的氨基末端和RING域在p53调节中的作用.
- 要了解Mdm4如何调节Mdm2在p53抑制中的功能.
主要方法:
- 产生具有特定Mdm4域删除 (Mdm4ΔR) 或完全丢失 (Mdm4─) 的小鼠模型.
- 在这些小鼠模型中分析p53水平和活性.
- 在p53调控中研究Mdm4-Mdm2相互作用.
主要成果:
- Mdm4ΔR小鼠显示p53水平和活性增加,比Mdm4─小鼠少.
- Mdm4的氨基末端有助于抑制p53.
- Mdm4调节了Mdm2对p53稳定性的调节,特别是在突变的p53背景下.
结论:
- Mdm4通过其氨基末端和RING域抑制p53.
- Mdm4对p53的抑制功能部分通过调节Mdm2活性来调节.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K

